Wednesday, September 21, 2016 - Thursday, September 21, 2017 12:00 AM
At the conclusion of this activity, participants should be able to:
- Explain why the live-attenuated intranasal influenza vaccine is no longer recommended;
- Identify which group of infected children will truly benefit from the use of antiviral therapy; and
- Identify why we are still unable to prevent all influenza infections in young infants.
Indiana University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Indiana University School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits
™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.